Long-term hematopoietic dysfunction in patients with large-scale mitochondrial DNA deletion syndromes

Pediatr Blood Cancer. 2025 Jan;72(1):e31383. doi: 10.1002/pbc.31383. Epub 2024 Oct 13.

Abstract

Background: Pearson syndrome (PS) and Kearns-Sayre syndrome (KSS) are single large-scale mitochondrial DNA deletion (SLSMD) syndromes. PS is characterized by severe, transient childhood cytopenia, whereas KSS typically manifests later in life without hematologic abnormalities. Despite distinct clinical presentations, both share a common mitochondrial DNA deletion. Recent observations suggest a potential link between PS progression and myeloid malignancy development, indicating that bone marrow failure (BMF) may be a key aspect of PS pathology and potentially universal across SLSMDs.

Methods: This study explores longitudinal hematological manifestations of SLSMD syndromes, focusing on bone marrow (BM) dysfunction.

Results: Sixteen patients with SLSMDs (13 PS and 3 KSS) were followed, of whom 75% experienced cytopenia, necessitating blood transfusions in 56%. Despite achieving transfusion independence at a median age of 24 months, persistent hematological abnormalities were noted. Comprehensive longitudinal BM studies were conducted in 62% of subjects and consistently revealed signs of marrow dysfunction, even without concurrent cytopenia. Median BM cellularity at a median age of four years and eight months was 50%, with histological signs of dyserythropoiesis, abnormal megakaryocytes, and signs suggesting myelodysplasia. Reduced CD34+ counts and BM colony-forming unit capacity were noted, alongside chromosome 7 aberrations in 16% of patients on cytogenetic studies.

Conclusions: Our findings establish BM dysfunction as a persistent hallmark of SLSMD syndromes, posing a risk of clonal evolution and acquisition of chromosome 7 aberrations. This aligns with recent literature, emphasizing enduring BMF in SLSMD syndromes and advocating for tailored hematological monitoring guidelines for this unique patient cohort.

Keywords: Hematopoietic dysfunction; Kearns‐Sayre syndrome; Pearson syndrome; monosomy 7; myelodysplasia; single large‐scale mitochondrial deletion syndromes.

MeSH terms

  • Acyl-CoA Dehydrogenase, Long-Chain* / deficiency
  • Acyl-CoA Dehydrogenase, Long-Chain* / genetics
  • Adolescent
  • Bone Marrow Failure Disorders / genetics
  • Bone Marrow Failure Disorders / pathology
  • Child
  • Child, Preschool
  • Congenital Bone Marrow Failure Syndromes* / genetics
  • Congenital Bone Marrow Failure Syndromes* / pathology
  • DNA, Mitochondrial* / genetics
  • Female
  • Follow-Up Studies
  • Humans
  • Infant
  • Kearns-Sayre Syndrome* / genetics
  • Kearns-Sayre Syndrome* / pathology
  • Lipid Metabolism, Inborn Errors* / complications
  • Lipid Metabolism, Inborn Errors* / genetics
  • Lipid Metabolism, Inborn Errors* / pathology
  • Longitudinal Studies
  • Male
  • Mitochondrial Diseases* / complications
  • Mitochondrial Diseases* / genetics
  • Mitochondrial Diseases* / pathology
  • Muscular Diseases / genetics
  • Muscular Diseases / pathology

Substances

  • Acyl-CoA Dehydrogenase, Long-Chain
  • DNA, Mitochondrial

Supplementary concepts

  • VLCAD deficiency